INTRODUCTION
The incidence rate of cancer of the colon and rectum increases with age. The incidence rate of colorectal cancer (CRC) per 100,000 individuals aged 80 years was by seven times higher than that of those aged 50-54 years (13) . Extending life expectancy is one of the major causes for increasing cancer incidence rate. Morbidity in 30-year old patients is 4/100000, while in 80-year ones it reaches up to 120/100000. The most affected group of rectal cancer (RC) is aged between 50 and 70 years. The main criterion for evaluating the results after surgical treatment is five-year survival rate. For the patients in I and II clinical stage it is about 60-80%. Liver metastasis (synchronous in 35% and metachronous in 25% of the cases) remains a hardly surmountable diagnostic and therapeutic problem in RC. In our own series, RC incidence rate is highest in the 6th and 7th decade of patient's life. Endoscopy has turned into the golden standard for CRC diagnosis. In some cases it is the method of choice in the treatment of the disease, too. The examination is applicable in 75-85% of all the patients as patient's selection and specialist's experience influence upon these numbers. The results from the histopathological examination of the materials obtained during the endoscopic biopsy match those from the post-operative morphological evaluation in 78-84% of the cases.
Our own results from the routine application of endoscopic techniques with narrow band imaging (NBI) mode colonoscopy show a higher rate of detection of premalignant and early forms of CRC when compared with studies applying conventional colonoscopy only. Various clinical trials evaluate the importance of NBI with or without magnification in order to improve the diagnostic value of colonoscopy (2, 5, 8, 11) . Some of them demonstrate an advantage of the method in terms of early diagnosis of adenocarcinoma (5, 11) . According to other authors, this method can accurately predict histological diagnosis in approximately 90% of hyperplastic polyps and adenomas (2, 8) , however, it cannot be recommended for routine application in the clinical practice yet (5, 11) .
NBI colonoscopy gives better chance for differentiation of the non-adenomatous from the adenomatous polyps of the colon sized less than one mm, as well as of the polyps with lowgrade dysplasia from those with a high-grade one and early cancer (2, 5, 8, (11) (12) (13) . NBI colonoscopy demonstrates comparable sensitivity (100%) and specificity (75%) with chromoendoscopy concerning the differentiation between neoplastic and non-neoplastic polyps. The results are better in comparison to standard colonoscopy (12) . In regard of diagnopsis of small polyps both methods show equal sensitivity, specificity and accuracy (2, 5) . NBI colonoscopy increases the chance of finding the new additional adenomas in case of hereditary nonpolypous colon cancer (CC) (12) and the number of diagnosed adenomas by two times. Its application in risk groups for RC is advisory, especially for sessile adenomas (9) .
MATERIAL AND METHODS
We examined the patients hospitalized in the First Clinic of Surgery, St. Marina University Hospital of Varna, for a period from 2010 to 2012. In such a set of objectives and tasks based on long experience in the Clinic of Surgery in terms of miniinvasive methods of RC treatment in a division with advanced miniinvasive endoscopic surgery, we decided to study the prospective group of patients with precancerous lesions and early CRC for a period from 2010 to 2012. During this period, 652 patients with symptoms of intestinal discomfort, changes in defecation rhythm, rectorhagia and hematohesia, asthenia, and anemia-adynamic syndrome were examined. All the patients included in our prospective study were treated according to a newly-implemented algorithm for early detection, accurate staging and radical treatment of precancerous and early forms of RC.
In 170 patients, 196 lesions of the colon and rectum were found out. In the present study, 163 patients suitable for total colonoscopy to the caecum and thus meeting the inclusion criteria were covered. They presented with a total of 184 newly-diagnosed lesions.
RESULTS
The results of our study demonstrated that NBI colonoscopy with magnifying endoscopy had the potential to detect more lesions remaining not identified by conventional endoscopy. The relative share of newly-increased mucosal changes increased by 1,9 times (52%). The newly-diagnosed lesions were mostly small sized. We diagnosed by 2,7 times more lesions sized less than one mm as well as by two times, 1,7 and 1,3 times more lesions sized 1-3 mm, 3-5 mm and 5-9 mm, respectively. The method did not establish any new formations larger than one cm or more. The main part of the newly-detected lesions presented with non-specific inflammatory changes, i. e. by 9,2 times more often when compared to conventional endoscopy and represented hyperplastic/inflammatory polyps by 2-3 times more often. In four new lesions there were either an early cancer, or areas of high-grade dysplasia while in 12 ones there was a low-grade dysplasia.
NBI colonoscopy increased the visual field which allowed preoperative assessment of invasion depth of CC, i. e. to distinguish invasive from noninvasive CC without further staining. The diagnostic accuracy was of 87,7% for the differentiation of pM or pSM1 from pSM2-3 being similar to that of magnification chromoendoscopy (87%) (1,9,10) . Thus, endoscopic CC removal was indicated in case of III-A changes of the capillary network, while lesions classified as type III-B were more likely to have deep infiltration of colon mucosa (1, 9, 10) .
Magnified NBI colonoscopy is a reliable method for diagnosing the small colonic neoplasms, especially those under five mm in size, for differentiating the non-adenomatous from adenomatous polyps of the colon as well as the polyps with low grade dysplasia from those with high grade one and carcinoma in situ. In addition, it allows mucous carcinoma to be separated from a carcinoma invading the submucous layer. We used the Paris classification for a better staging and classification of recently detected lesions of the colon and rectum.
There is an obvious advantage of NBI colonoscopy over conventional colonoscopy (Table 1) .
Flat and concaved lesions prevail in our contingent ( Table 2) . Because of unsatisfactory colon preparation, NBI colonoscopy has failed to identify three lesions (1,63%) in three patients which have been detected by conventional colonoscopy.
It is evident that routine NBI-regime usage significantly increases the rate of detection of recent Table 4 it can be seen that the difference of time duration between both methods of 2 min and 20 sec or of 17% is not significant.
Excellent and satisfactory visualization of the lesions was achieved in 77% of the cases in the conventional group and in 94% in the NBI-assisted one (Fig. 1) .
DISCUSSION
Early RC detection and diagnosis are the key strategies for decreasing the recurrence rate and increasing patient's survival. Endoscopy has turned into the golden standard for RC diagnosis. In some cases it is the method of choice in the treatment of the disease, too. The examination is applicable in 75-85% of all the patients where their selection and specialist's experience influence on these numbers. The results from the histopathological examination of the materials obtained during the endoscopic biopsy match those from the post-operative morphological evaluation in 78-84% of the cases.
Due to the routine use of endoscopic methods with NBI-assisted regimes in our study, detection of premalignant and early CRC is comparatively higher than in studies using conventional endoscopy. Different clinical studies evaluate the role of NBI with or without magnification to improve the diagnostic value of colonoscopy (5, 9, 10, 12) . Some of them show advantages of this method regarding the diagnosis of early adenocarcinoma. According to other authors, this method can predict the exact histological diagnosis in approximately 90% for the hyperplastic polyps and adenomas (1, 6, 10) , however, it is not recommended for routine clinical use yet (4, 12) .
The results from our study show that NBI with magnifying endoscopy gives the opportunity to diagnose lesions not established via conventional endoscopy. The rate of the newly-detected superficial changes increased by 1,9 times or by 52%. They were of comparatively smaller size. Thus we diagnosed by 2,7 times more lesions sized less than one mm as well as by two times, 1,7 and 1,3 times more lesions sized 1-3 mm, 3-5 mm and 5-9 mm, respectively. The method did not establish any new formations larger than one cm or more. The main part of the newly-detected lesions presented with non-specific inflammatory changes, i. e. by 9,2 times more often when compared to conventional endoscopy and represented hyperplastic/inflammatory polyps by 2-3 times more often. In four new lesions there were either an early cancer, or areas of high-grade dysplasia while in 12 ones there was a low-grade dysplasia.
NBI increases the rate of differentiation between non-adenomatous and adenomatous polyps of the colon of less than one mm in size as well as between polyps with low-grade dysplasia and those with high-grade one and early carcinoma (7, 8, 13) . NBI demonstrates a similar sensitivity (100%) and specificity (75%) to chromoendoscopy when differentiating between neoplastic and nonneoplastic lesions being better than standard colonoscopy. Concerning the diagnosis of small polyps, both methods show one and the same sensitivity, specificity and accuracy (2, 5) . NBI increases the chance of detection of additional adenomas in patients with hereditary non-polypous CC (3) . The number of adenomas that are identified by NBI colonoscopy increases twofold. The application of this method is recommended in risk groups for RC and for diagnosis of flat adenomas (6) .
Our own and other authors' results confirm the clinical significance of the higher accuracy and lower percentage of false-positive or negative results (5, 7, 9, 10) .
Endoscopic removal of colonic tumours is indicated in III-A changes in the capillary network while lesions classified as type III-B most often infiltrate the lining of the colon in depth (1, 9, 10 neoplasms of the colon and, especially, of those less than five mm in size, for the differentiation of nonadenomatous from adenomatous polyps as well as of polyps with high-grade dysplasia from those with low-grade one. In addition, it can help differentiating the mucous cancer from the cancer invading the submucous layer.
